The same authors have found that silencing HIF-1α sensitizes HCC cells to sorafenib, suggesting that hypoxia-induced HIF-1α correlates with sorafenib resistance (Figure 6A). The gene discussed is HIF1A; the disease is hepatocellular carcinoma.